Medical Devices Startups
6,551 companies tagged Medical Devices, with their investors and founders.
PharmAdva makes the MedaCube, a smart automated pill dispenser that helps patients take prescribed medications correctly and lets caregivers and physicians monitor in-home medication adherence in real time. The device targets people who struggle to manage their medications, supporting independent living and reduced hospitalization.
0 investors
Phigenix develops personalized medicine for cancer, including companion diagnostics and targeted therapies for prostate and breast cancer patients. Its work centers on early detection and targeted inhibition of PAX2 and EN2 oncogenes and a cancer vaccine using Human Beta Defensin-1 (DEFB1) mRNA to direct the immune system against cancer cells.
0 investors
pHLIP Inc. develops a peptide-based targeted delivery platform (pHLIP, pH-Low Insertion Peptide) that selectively delivers therapeutic and imaging agents to acidic cells in diseased tissues. The technology targets cancer, inflammation, and other acidic tissue diseases by marking, reprogramming, or killing acidic cells.
0 investors
PhotonPharma develops riboflavin and UV-based treatment technology (disposables and equipment) optimized for cancer immunotherapy and vaccine production. The company works with Colorado State University's School of Biomedical Engineering and external consultants to advance its immunotherapy platform.
0 investors
PhysioWave develops medical devices that measure Pulse Wave Velocity, a key cardiovascular health marker, in under a minute during routine clinical workflows. The company creates clinical-grade and home versions of its technology to identify individuals at high risk of cardiovascular disease.
0 investors
Piezotx develops Piezopen, a drug delivery platform that combines piezoelectric pulses with microneedle electrodes to deliver "naked" RNA and DNA without lipid nanoparticles or viral vectors. The company partners with startups and pharmaceutical companies on genetic medicines across infectious disease vaccines, immuno-oncology, chronic disease, and dermatology.
0 investors
Pike develops a multi-day, continuous-delivery patch formulation of dronabinol to address non-motor symptoms in Parkinson's Disease and agitation in Alzheimer's and dementia patients.
0 investors
Pillsy offers an enterprise platform and connected medication hardware for remote patient support, including smart dose reminders, adherence tracking via a sensor-equipped bottle, refill ordering, and integration with Bluetooth/cellular monitoring devices. Its HIPAA-compliant software serves patient support services, specialty pharmacies, and healthcare providers, and lets partners build custom connected medication apps.
0 investors
Pinnacle Transplant Technologies processes and distributes allograft implants — including demineralized bone matrix products, soft tissue grafts, structural grafts, and amniotic membranes — for orthopedic and wound healing applications. It also offers contract manufacturing and private-labeled implants for medical device customers.
0 investors
PinPoint Testing provides analytical laboratory services and consulting for the detection of drugs, environmental hazards, food toxins, and industrial contaminants, serving pharmaceutical, clinical, forensic, and government laboratories. The company operates a CLIA and ISO 17025-accredited forensic testing lab and offers ToxBox product solutions and reference laboratory services.
0 investors
Piraeus Medical develops catheters built with a patented linerless construction, including the NeuGlide+ (0.087" inner diameter, compatible with a 7F introducer sheath) and NeuFlex (0.093" inner diameter, compatible with an 8F introducer sheath). It operates in the medical device sector.
0 investors
Plasmology4 develops Plaz4, a non-thermal (cold) plasma technology for medical applications, with its first product, the Plaz4 1000 system, aimed at treating antibiotic-resistant infections and chronic non-healing wounds. It is a pre-revenue medical device company in the emerging field of plasma medicine, and its lead product has received FDA Breakthrough Device designation but is not yet approved for sale.
0 investors
PTX is a biotech company developing therapeutic solutions to mitigate adverse side effects associated with cancer chemotherapy and other medical treatments. The company focuses on improving patient quality of life during medical therapies through drug development.
0 investors
Plexiform Bio is developing non-invasive treatments for retinal vascular diseases, which are currently treated primarily through injections into the eye. The company aims to offer alternatives to frequent, uncomfortable eye injections for patients with retinal conditions that cause blurred vision.
0 investors
Pluristyx develops induced pluripotent stem cell (iPSC) technologies, including non-modified and genetically engineered cell lines, proprietary gene edits, and reprogramming platforms, along with related services. It provides these products and end-to-end development support to companies building cell and stem cell therapies.
0 investors
PNP Therapeutics is a clinical-stage biopharmaceutical company developing Gedeptin, a platform technology for cancer treatment that programs tumors to generate their own chemotherapy through a patented enzyme and prodrug system. The company targets patients with solid tumors including prostate, breast, colon, lung, brain, melanoma, pancreas, ovarian, and kidney cancers.
0 investors
PolyVascular develops a polymer-based transcatheter pulmonary heart valve for pediatric patients with congenital heart conditions. The medical device company focuses on providing durable, minimally invasive valve replacements for children.
0 investors
Port Warwick Surgery Center provides ambulatory surgical care and pre-operative testing, anesthesia, and post-operative nursing services for patients undergoing procedures. The center is accredited by the Accreditation Association for Ambulatory Health Care and emphasizes safety and quality in its surgical operations.
0 investors
Portela Soni Medical (PSM) is a medical device company developing a catheter, drawing on clinical expertise in urology and nursing. The company focuses on catheterization technology, including infection-reducing catheter design.
0 investors
PreciseDx develops molecular pathology diagnostic tools for cancer care, combining anatomical pathology with molecular and systems biology to enable precise diagnosis and treatment planning. The company's flagship product serves pathologists and oncologists seeking data-driven insights for patient risk stratification and personalized cancer care.
0 investors
Precision Biologics develops therapeutic and diagnostic products for cancer patients. The company operates in the oncology biotech space in the United States.
0 investors
Precision Epigenomics develops EPISEEK, a blood-based multi-cancer early detection test that analyzes hypermethylated DNA loci to identify DNA changes linked to over 60 cancer types before symptoms appear. The test serves higher-risk individuals, health-conscious people aged 45+, healthcare providers, and wellness programs, with lab analysis performed at a CAP-accredited, CLIA-certified lab.
0 investors
Neuropharmagen provides genetic testing and analysis to help healthcare providers identify the most effective psychotropic medications and dosages for patients with mental health conditions such as depression, anxiety, and bipolar disorder.
0 investors
Predictive Oncology develops drug discovery solutions for biopharma companies that combine artificial intelligence with a proprietary biobank of over 150,000 tumor samples to accelerate oncology drug development and improve therapeutic outcomes for cancer patients.
0 investors